Immupharma PLC - Change of Registered Office Address
RNS: FOR IMMEDIATE RELEASE
("ImmuPharma" or the "Company")
Notification of Change of Registered Office Address
ImmuPharma PLC (LSE:IMM), (Euronext Growth Brussels: ALIMM), the specialist drug discovery and development company announces that with immediate effect, its registered office address has been changed to: One Bartholomew Close, London, EC1A 7BL.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 ("MAR").
For further information please contact:
Notes to Editors
This information is provided by RNS, the news service of the
Quick facts: ImmuPharma PLC
Market Cap: £25.62 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE